Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
- 15 February 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 93 (4) , 704-711
- https://doi.org/10.1161/01.cir.93.4.704
Abstract
Background Tumor necrosis factor-α (TNF-α) is a proinflammatory cytokine that produces negative inotropic effects in the heart. Recently, elevated levels of TNF-α have been reported in patients with advanced congestive heart failure. Although TNF-α is thought to exert its deleterious effects by binding to two cell surface receptors, TNFR1 and TNFR2, the level of expression and regulation of TNF receptors in the heart in cardiac disease states is not known. Methods and Results We examined mRNA and protein levels for TNFR1, TNFR2, and TNF-α in explanted hearts from organ donors as well as in patients with end-stage dilated cardiomyopathy (DCM) and ischemic heart disease (IHD). Northern blot analysis revealed that mRNA for TNFR1 and TNFR2 was present in nonfailing, DCM, and IHD hearts. TNFR1 and TNFR2 receptor protein levels, as measured by ELISA, were decreased 60% in DCM and IHD patients compared with nonfailing hearts (P<.005). To determine a potential mechanism for the decrease in TNF receptor expression, we measured levels of circulating soluble TNF receptors (sTNFRs) in DCM and IHD patients. This analysis showed that there was a significant one-and-a-half to threefold increase in sTNFRs in DCM (P<.03) and IHD patients (P<.001). Another important finding was that TNF-α mRNA and TNF-α protein were present in the explanted hearts from DCM and IHD patients but not in nonfailing hearts. Conclusions In summary, the results of this study constitute the initial demonstration that TNF receptor proteins are dynamically regulated in patients with advanced congestive heart failure. Moreover, the observation that failing hearts express elevated levels of TNF-α suggests that overexpression of this cytokine may be one of several different maladaptive mechanisms responsible for the progressive cardiac decompensation that occurs in advanced heart failure.Keywords
This publication has 39 references indexed in Scilit:
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy.Heart, 1994
- Increased levels of serum neoprotein and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alphaJournal of the American College of Cardiology, 1993
- Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Journal of Clinical Investigation, 1993
- Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric OxideScience, 1992
- Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Heart, 1991
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Lipoprotein lipase in heart cell cultures is suppressed by bacterial lipopolysaccharide: an effect mediated by production of tumor necrosis factorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- A human inhibitor of tumor necrosis factor alpha.The Journal of Experimental Medicine, 1988
- Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.Journal of Clinical Investigation, 1986